Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aradigm Corp (ARDM)

Aradigm Corp (ARDM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,826
  • Shares Outstanding, K 15,220
  • Annual Sales, $ 14,470 K
  • Annual Income, $ -10,710 K
  • 60-Month Beta 2.46
  • Price/Sales 1.32
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/22/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0701 +71.18%
on 02/19/19
0.8001 -85.00%
on 01/22/19
-0.4900 (-80.33%)
since 01/18/19
3-Month
0.0701 +71.18%
on 02/19/19
1.2500 -90.40%
on 12/11/18
-0.8700 (-87.88%)
since 11/19/18
52-Week
0.0701 +71.18%
on 02/19/19
2.3300 -94.85%
on 06/20/18
-1.1800 (-90.77%)
since 02/16/18

Most Recent Stories

More News
Aradigm Announces Receipt of Final FDA Minutes for the Type B Meeting on January 25, 2019

Aradigm Corporation (Pink Market: ARDM) ("Aradigm" or the "Company").

ARDM : 0.1200 (-73.91%)
Aradigm Announces Detailed Third Party Evaluation Results for Apulmiq (FDA)/Linhaliq (EMA)

Aradigm Corporation (OTCQB: ARDM) ("Aradigm" or the "Company") today announced specific, detailed results of an independent third party evaluation (TPE) of the Phase 3 clinical trial results...

ARDM : 0.1200 (-73.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ARDM with:

Key Turning Points

2nd Resistance Point 0.4599
1st Resistance Point 0.2900
Last Price 0.1200
1st Support Level 0.0101
2nd Support Level 0.0000

See More

52-Week High 2.3300
Fibonacci 61.8% 1.4667
Fibonacci 50% 1.2000
Fibonacci 38.2% 0.9334
Last Price 0.1200
52-Week Low 0.0701

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar